Pharmaceuticals news and pharmaceuticals widget
Tuesday, November 18, 2008 ( change date )
Photocure?s Cevira shows positive interim results for treatment of precancerous lesions of the cervix
Photocure presented positive interim data at the six-month follow up stage of its phase I/II clinical feasibility study with Cevira? at the EUROGIN 2008 international conference. Cevira? is ...
bionity.com Tuesday, November 18, 2008The Three Leading Independent Proxy Advisory Firms Recommend Stockholders Vote ''For'' Rite Aid's Reverse Stock Split
Rite Aid Corporation (NYSE: RAD) said today that all three of the leading independent proxy advisory firms have recommended stockholders support the Board of Directors' plan for a reverse split of Rit... [WebWire - Tuesday, november 18, 2008]
Webwire Tuesday, November 18, 2008WACKER and MorphoSys Intensify Cooperation to Use WACKER Technology for Production of Antibodies
Joint press release of WACKER and MorphoSys - - Munich/Jena, Wacker Chemie AG and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) are intensifying their cooperation in the use of WACKER's proka... [WebWire - Tuesday, november 18, 2008]
Webwire Tuesday, November 18, 2008Galapagos and Merck Serono enter new collaboration agreements
Mechelen, Belgium - Galapagos NV (Euronext: GLPG) announced today new collaboration agreements with Merck Serono, a division of Merck KGaA, Darmstadt, Germany. Total value of the contracts for Galapag... [WebWire - Tuesday, november 18, 2008]
Webwire Tuesday, November 18, 2008Israel Stocks: Tel Aviv lower; Teva up as it completes MS-drug trial
Israel stocks fell for a seventh session, with the banks, turbine producer Ormat, and Israel Chemicals dragging the benchmark index lower.
Market Watch Tuesday, November 18, 2008Icon to manage Eli Lilly ex-U.S. clinical data management
LONDON (MarketWatch) -- Icon plc said it's signed an agreement to manage Eli Lilly & Co.'s clinical data management business outside the United States and Japan. Terms weren't disclosed.
Market Watch Tuesday, November 18, 2008American College of Physicians: American College of Physicians Finds No Substantial Differences Among ''Second-Generation'' Antidepressant Drugs
PHILADELPHIA, PA (MARKET WIRE) The American College of Physicians is publishing a new guideline for the treatment of depression in Annals of Internal Medicine. ACP found no substantial differences in efficacy or quality of life among "second-generation" antidepressants used to treat depressive disorders such as major depressive disorder. ACP recommends that physicians make treatment decisions based on side effects, cost, and patient preferences, and make necessary changes in therapy if the response is not sufficient after six to eight weeks. Doctors should also assess patient status and adverse effects on a regular basis
Marketwire.com Tuesday, November 18, 2008Ginkgo Evaluation of Memory (GEM) Study Fails To Show Benefit in Preventing Dementia in the Elderly
The dietary supplement Ginkgo biloba was found to be ineffective in reducing the development of dementia and Alzheimer's disease in older people, according to a study published in the Journal of the A... [WebWire - Tuesday, november 18, 2008]
Webwire Tuesday, November 18, 2008Dancing droplets
Our blood, sweat and tears are three precious fluids that can answer lots of questions about the state of our health but testing small amounts of bodily fluids, without contaminating them through ...
bionity.com Tuesday, November 18, 2008Frost & Sullivan: Will Big Pharma Embrace its Orphans?
While most big pharmaceutical and biotechnology companies have traditionally depended on blockbuster molecules, it is estimated that $90.0 billion worth of ethical molecules will come off patent ...
bionity.com Tuesday, November 18, 20081 2

PREVIEW
OF YOUR NEWS WIDGET
INSTALL YOUR WIDGET